The BioSelact™ platform enhances and accelerates the discovery and optimization of lead drug candidates. The platform allows direct screening of mixtures of compounds. The BioSelact™ platform combines high-resolution separation with a variety of in-line assays, allowing simultaneous determination of biological activity as well as physicochemical properties of individual compounds in a complex mixture of chemicals. Additionally, Kiadis Pharma has its own proprietary compound libraries from natural and synthetic sources.